Expression Pathology has established important relationships with a range of different companies and institutions. Our collaborators include tissue providers, mass spectrometry analysis laboratories and bioinformatics companies.
Expression
Pathology Inc. (EPI) is a leader in tissue
microproteomics. Our technologies make possible mass spec protein analysis
of formalin-fixed tissue,
enabling discovery, validation and routine
measurement of protein biomarkers related to clinical outcomes. Our near-term
mission is
to offer breakthrough research tools and
collaborations to improve drug and diagnostic development and for basic
research. Our proprietary
technologies also provide the foundation
for a whole new platform of tissue diagnostic tests currently under development.
The Liquid Tissue® MS protocol prepares FFPE samples
for mass spec analysis. Complete solubilization captures the entire protein
content. Mass spec friendly. Requires only 30,000 cells for multiple
mass spectrometry analyses.
The Director™ Laser Microdissection Slides
provide the fastest, easiest and most accurate way to collect specific
cellular features from tissue sections. Engineered for use with existing
Leica LMD and PALM Zeiss laser microdissection system.
Investors
We are seeking investments and collaboration opportunities.
For more information please contact our business development
group.
email
b u s d e v @ e x p ressi o n p a t h o l o g y d
o t c o m
